FA
GSK icon

Financial Advantage’s GSK GSK Stock Holding History

Financial Advantage’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-146
Closed -$7K – 130
2022
Q1 		$7K Sell
146
-1,454
-91% -$79K 0.01% 122
2021
Q4 		$88K Buy
+1,600
New +$83.2K 0.07% 51
2014
Q1 		– Sell
-16
Closed -$1K – 159
2013
Q4 		$1K Hold
16
– – ﹤0.01% 216
2013
Q3 		$1K Hold
16
– – ﹤0.01% 200
2013
Q2 		$1K Buy
+16
New +$1.02K ﹤0.01% 207

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Financial Advantage's GSK Position: Q2 2022 in Review

Financial Advantage sold out of GSK (GSK) in Q2 2022, closing a stake of 146 shares — an estimated $7K sold.

Financial Advantage first reported a position in GSK in Q2 2013 and held it in 5 quarters. The position peaked at $88K in Q4 2021. 900 funds tracked by Wall St. Rank hold GSK as of Q2 2022.

  • Financial Advantage reported no remaining GSK position as of Q2 2022 after selling out during the quarter.
  • Financial Advantage sold 146 GSK shares in Q2 2022, an estimated $7K.
  • Financial Advantage first reported a position in GSK in Q2 2013 and held it in 5 quarters.
  • Financial Advantage's GSK position peaked at $88K in Q4 2021.
  • 900 funds tracked by Wall St. Rank held GSK as of Q2 2022.

Based on Financial Advantage's 13F filing for Q2 2022, filed 1 Aug 2022.